Treatment outcomes of metastasis-directed treatment using68Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002)

Sadeleştirilmiş öğe sayfası
dc.contributor.authorHurmuz, Pervin
dc.contributor.authorOnal, Cem
dc.contributor.authorOzyigit, Gokhan
dc.contributor.authorIgdem, Sefik
dc.contributor.authorAtalar, Banu
dc.contributor.authorSayan, Haluk
dc.contributor.authorAkgun, Zuleyha
dc.contributor.authorKurt, Meral
dc.contributor.authorOzkok, Hale Basak
dc.contributor.authorSelek, Ugur
dc.contributor.authorOymak, Ezgi
dc.contributor.authorTilki, Burak
dc.contributor.authorGuler, Ozan Cem
dc.contributor.authorMustafayev, Teuto Zoto
dc.contributor.authorSaricanbaz, Irem
dc.contributor.authorRzazade, Rashad
dc.contributor.authorAkyol, Fadil
dc.date.accessioned2025-10-16T15:21:12Z
dc.date.issued2020
dc.identifier.doi10.1007/s00066-020-01660-6
dc.identifier.otherWOS:000545850300001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/7631
dc.publisherSPRINGER HEIDELBERG
dc.sourceSTRAHLENTHERAPIE UND ONKOLOGIE
dc.subjectProstate adenocarcinoma
dc.subjectStereotactic body radiotherapy
dc.subjectPSMA PET
dc.subjectOligometastasis
dc.subjectSurvival
dc.titleTreatment outcomes of metastasis-directed treatment using68Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002)
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS